I looked up breast cancer survival numbers by country and the US looks about on par with the rest of the developed world.

I do agree with your general sentiment that there’s a lot of nuance that’s certainly worthy of deeper conversation. But I’m not sure that nuance accumulates into a meaningful argument for the system not being a scam when looking at the price tag.